Crossmark

2-Hydroxybenzohydrazide as a novel potential candidate against nociception, inflammation, and pyrexia: in vitro, in vivo, and computational approaches

Crossref DOI link: https://doi.org/10.1007/s10787-023-01356-0

Published Online: 2023-10-21

Published Print: 2024-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ali, Gowhar

Islam, Nazar Ul

Qaim, Muhammad

Ullah, Rahim

Jan, Muhammad Saeed

Shabbiri, Khadija

Shafique, Muhammad

Ayaz, Muhammad https://orcid.org/0000-0002-4299-2445
License Information

Text and Data Mining valid from 2023-10-21

Version of Record valid from 2023-10-21
More Information

Article History

Received: 7 July 2023

Accepted: 25 September 2023

First Online: 21 October 2023

Declarations

:

: The authors declare no conflict of interest.

: Not applicable.

: The animal studies of the project were performed at Department of Pharmacy, University of Peshawar, Pakistan and the project was evaluated and approved by the Animal ethics committee of the same Department.

Document is current

Any future updates will be listed below